#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4718381	B	Inhibition of human erythrocytes mu-calpain using Pep1 as substrate incubated for 30 mins under shaking condition in presence of CaCl2 by fluorescence assay	Homo sapiens	16		tissue-based format	Scientific Literature
2.	ALA4718382	B	Inhibition of cathepsin B (unknown origin) using RR-AMC as substrate preincubated for 30 mins followed by substrate addition and further incubated for 30 mins under shaking condition by fluorescence assay	Homo sapiens	16		single protein format	Scientific Literature
3.	ALA4718383	B	Inhibition of cathepsin L (unknown origin) using Z-FR-AMC as substrate preincubated for 30 mins followed by substrate addition and further incubated for 30 mins under shaking condition by fluorescence assay	Homo sapiens	16		single protein format	Scientific Literature
4.	ALA4718386	B	Inhibition of mu-calpain (unknown origin) expressed in SH-SY5Y cells assessed as reduction in p35 cleavage at 20 uM using p35 as substrate measured after 210 mins by fluorescence microplate reader assay	Homo sapiens	2		cell-based format	Scientific Literature
5.	ALA4718389	B	Inhibition of mu-calpain (unknown origin) expressed in HEK293T cells assessed as reduction in p35 cleavage at 5 uM using p35 as substrate measured after 210 mins by fluorescence microplate reader assay	Homo sapiens	2		cell-based format	Scientific Literature
6.	ALA4718392	B	Inhibition of cathepsin B in human SH-SY5Y cells using RR-AMC as substrate by fluorescence microplate reader assay	Homo sapiens	3		cell-based format	Scientific Literature
7.	ALA4718393	F	Neuroprotective activity in human SH-SY5Y cells assessed as reduction in GOx-induced PARP cleavage at 5 uM pretreated with GOx for 4 hrs followed by compound treatment by Western blot analysis	Homo sapiens	2		cell-based format	Scientific Literature
8.	ALA4718395	F	Neuroprotective activity in human SH-SY5Y cells assessed as reduction in GOx-induced caspase 3 cleavage pretreated with GOx for 4 hrs followed by compound treatment by Western blot analysis	Homo sapiens	2		cell-based format	Scientific Literature
9.	ALA4718396	B	Inhibition of mu-calpain/cathepsin B in human SH-SY5Y cells assessed as reduction in GOx-induced BACE1 upregulation at 20 uM pretreated with GOx for 4 hrs followed by compound treatment by Western blot analysis	Homo sapiens	2		cell-based format	Scientific Literature
10.	ALA4718397	F	Reduction in GOx-induced amyloid beta(1 to 42) level in human SH-SY5Y cells pretreated with GOx for 4 hrs followed by compound treatment by sandwich ELISA	Homo sapiens	2		cell-based format	Scientific Literature
11.	ALA4718398	B	Inhibition of mu-calpain in human SH-SY5Y cells assessed as reduction in GOx-induced MAPK phosphorylation pretreated with GOx for 4 hrs followed by compound treatment by Western blot analysis	Homo sapiens	2		cell-based format	Scientific Literature
12.	ALA4718399	B	Inhibition of mu-calpain in human SH-SY5Y cells assessed as reduction in GOx-induced p25 phosphorylation pretreated with GOx for 4 hrs followed by compound treatment by Western blot analysis	Homo sapiens	2		cell-based format	Scientific Literature
13.	ALA4718400	B	Inhibition of mu-calpain in human SH-SY5Y cells assessed as reduction in tau phosphorylation by Western blot analysis	Homo sapiens	2		cell-based format	Scientific Literature
14.	ALA4718401	B	Competitive inhibition of human erythrocytes mu-calpain using varying level of Pep2 as substrate by Lineweaver-Burk plot analysis	Homo sapiens	2		tissue-based format	Scientific Literature
15.	ALA4718402	B	Competitive inhibition of cathepsin B (unknown origin) using varying level of RR-AMC as substrate by Lineweaver-Burk plot analysis	Homo sapiens	2		single protein format	Scientific Literature